img

Global Anti-Tuberculosis Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-Tuberculosis Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Tuberculosis is a chronic wasting infectious disease caused by Mycobacterium tuberculosis. The drugs used to treat this disease are anti-tuberculosis drugs.
Anti-Tuberculosis Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-Tuberculosis Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anti-Tuberculosis Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anti-Tuberculosis Drug key manufacturers include Lupin, Otsuka, Sanofi, Prizer, Abbott and NOVARTIS, etc. Lupin, Otsuka, Sanofi are top 3 players and held % sales share in total in 2022.
Anti-Tuberculosis Drug can be divided into First-Line Anti-Tuberculosis Drugs and Second-Line Anti-Tuberculosis Drugs, etc. First-Line Anti-Tuberculosis Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Anti-Tuberculosis Drug is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Anti-Tuberculosis Drug industry development. In 2022, global % sales of Anti-Tuberculosis Drug went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-Tuberculosis Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Lupin
Otsuka
Sanofi
Prizer
Abbott
NOVARTIS
Segment by Type
First-Line Anti-Tuberculosis Drugs
Second-Line Anti-Tuberculosis Drugs

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Anti-Tuberculosis Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anti-Tuberculosis Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anti-Tuberculosis Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Anti-Tuberculosis Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anti-Tuberculosis Drug introduction, etc. Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Anti-Tuberculosis Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Anti-Tuberculosis Drug Market Overview
1.1 Anti-Tuberculosis Drug Product Overview
1.2 Anti-Tuberculosis Drug Market Segment by Type
1.2.1 First-Line Anti-Tuberculosis Drugs
1.2.2 Second-Line Anti-Tuberculosis Drugs
1.3 Global Anti-Tuberculosis Drug Market Size by Type
1.3.1 Global Anti-Tuberculosis Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Anti-Tuberculosis Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Anti-Tuberculosis Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Tuberculosis Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Anti-Tuberculosis Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Anti-Tuberculosis Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Anti-Tuberculosis Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Anti-Tuberculosis Drug Sales Breakdown by Type (2018-2024)
2 Global Anti-Tuberculosis Drug Market Competition by Company
2.1 Global Top Players by Anti-Tuberculosis Drug Sales (2018-2024)
2.2 Global Top Players by Anti-Tuberculosis Drug Revenue (2018-2024)
2.3 Global Top Players by Anti-Tuberculosis Drug Price (2018-2024)
2.4 Global Top Manufacturers Anti-Tuberculosis Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Tuberculosis Drug Market Competitive Situation and Trends
2.5.1 Anti-Tuberculosis Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Tuberculosis Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Tuberculosis Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-Tuberculosis Drug Market
2.8 Key Manufacturers Anti-Tuberculosis Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Tuberculosis Drug Status and Outlook by Region
3.1 Global Anti-Tuberculosis Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Anti-Tuberculosis Drug Historic Market Size by Region
3.2.1 Global Anti-Tuberculosis Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Anti-Tuberculosis Drug Sales in Value by Region (2018-2024)
3.2.3 Global Anti-Tuberculosis Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Anti-Tuberculosis Drug Forecasted Market Size by Region
3.3.1 Global Anti-Tuberculosis Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Anti-Tuberculosis Drug Sales in Value by Region (2024-2034)
3.3.3 Global Anti-Tuberculosis Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anti-Tuberculosis Drug by Application
4.1 Anti-Tuberculosis Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Anti-Tuberculosis Drug Market Size by Application
4.2.1 Global Anti-Tuberculosis Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Anti-Tuberculosis Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Anti-Tuberculosis Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Tuberculosis Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Anti-Tuberculosis Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Anti-Tuberculosis Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Anti-Tuberculosis Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Anti-Tuberculosis Drug Sales Breakdown by Application (2018-2024)
5 North America Anti-Tuberculosis Drug by Country
5.1 North America Anti-Tuberculosis Drug Historic Market Size by Country
5.1.1 North America Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Anti-Tuberculosis Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Anti-Tuberculosis Drug Sales in Value by Country (2018-2024)
5.2 North America Anti-Tuberculosis Drug Forecasted Market Size by Country
5.2.1 North America Anti-Tuberculosis Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Anti-Tuberculosis Drug Sales in Value by Country (2024-2034)
6 Europe Anti-Tuberculosis Drug by Country
6.1 Europe Anti-Tuberculosis Drug Historic Market Size by Country
6.1.1 Europe Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Anti-Tuberculosis Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Anti-Tuberculosis Drug Sales in Value by Country (2018-2024)
6.2 Europe Anti-Tuberculosis Drug Forecasted Market Size by Country
6.2.1 Europe Anti-Tuberculosis Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Anti-Tuberculosis Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Anti-Tuberculosis Drug by Region
7.1 Asia-Pacific Anti-Tuberculosis Drug Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Anti-Tuberculosis Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Anti-Tuberculosis Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Anti-Tuberculosis Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Tuberculosis Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anti-Tuberculosis Drug Sales in Value by Region (2024-2034)
8 Latin America Anti-Tuberculosis Drug by Country
8.1 Latin America Anti-Tuberculosis Drug Historic Market Size by Country
8.1.1 Latin America Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Anti-Tuberculosis Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Anti-Tuberculosis Drug Sales in Value by Country (2018-2024)
8.2 Latin America Anti-Tuberculosis Drug Forecasted Market Size by Country
8.2.1 Latin America Anti-Tuberculosis Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anti-Tuberculosis Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Anti-Tuberculosis Drug by Country
9.1 Middle East and Africa Anti-Tuberculosis Drug Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Anti-Tuberculosis Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Anti-Tuberculosis Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Anti-Tuberculosis Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Tuberculosis Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anti-Tuberculosis Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Lupin
10.1.1 Lupin Company Information
10.1.2 Lupin Introduction and Business Overview
10.1.3 Lupin Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Lupin Anti-Tuberculosis Drug Products Offered
10.1.5 Lupin Recent Development
10.2 Otsuka
10.2.1 Otsuka Company Information
10.2.2 Otsuka Introduction and Business Overview
10.2.3 Otsuka Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Otsuka Anti-Tuberculosis Drug Products Offered
10.2.5 Otsuka Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi Anti-Tuberculosis Drug Products Offered
10.3.5 Sanofi Recent Development
10.4 Prizer
10.4.1 Prizer Company Information
10.4.2 Prizer Introduction and Business Overview
10.4.3 Prizer Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Prizer Anti-Tuberculosis Drug Products Offered
10.4.5 Prizer Recent Development
10.5 Abbott
10.5.1 Abbott Company Information
10.5.2 Abbott Introduction and Business Overview
10.5.3 Abbott Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Abbott Anti-Tuberculosis Drug Products Offered
10.5.5 Abbott Recent Development
10.6 NOVARTIS
10.6.1 NOVARTIS Company Information
10.6.2 NOVARTIS Introduction and Business Overview
10.6.3 NOVARTIS Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 NOVARTIS Anti-Tuberculosis Drug Products Offered
10.6.5 NOVARTIS Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Tuberculosis Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Tuberculosis Drug Industrial Chain Analysis
11.4 Anti-Tuberculosis Drug Market Dynamics
11.4.1 Anti-Tuberculosis Drug Industry Trends
11.4.2 Anti-Tuberculosis Drug Market Drivers
11.4.3 Anti-Tuberculosis Drug Market Challenges
11.4.4 Anti-Tuberculosis Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Tuberculosis Drug Distributors
12.3 Anti-Tuberculosis Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of First-Line Anti-Tuberculosis Drugs
Table 2. Major Company of Second-Line Anti-Tuberculosis Drugs
Table 3. Global Anti-Tuberculosis Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Anti-Tuberculosis Drug Sales by Type (2018-2024) & (K Units)
Table 5. Global Anti-Tuberculosis Drug Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Anti-Tuberculosis Drug Sales by Type (2018-2024) & (US& Million)
Table 7. Global Anti-Tuberculosis Drug Market Share in Value by Type (2018-2024)
Table 8. Global Anti-Tuberculosis Drug Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Anti-Tuberculosis Drug Sales by Type (2024-2034) & (K Units)
Table 10. Global Anti-Tuberculosis Drug Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Anti-Tuberculosis Drug Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Anti-Tuberculosis Drug Sales Market Share in Value by Type (2024-2034)
Table 13. Global Anti-Tuberculosis Drug Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Anti-Tuberculosis Drug Sales by Type (2018-2024) & (K Units)
Table 15. North America Anti-Tuberculosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Anti-Tuberculosis Drug Sales (K Units) by Type (2018-2024)
Table 17. Europe Anti-Tuberculosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Anti-Tuberculosis Drug Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Anti-Tuberculosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Anti-Tuberculosis Drug Sales (K Units) by Type (2018-2024)
Table 21. Latin America Anti-Tuberculosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Anti-Tuberculosis Drug Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Anti-Tuberculosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Anti-Tuberculosis Drug Sales by Company (2018-2024) & (K Units)
Table 25. Global Anti-Tuberculosis Drug Sales Share by Company (2018-2024)
Table 26. Global Anti-Tuberculosis Drug Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Anti-Tuberculosis Drug Revenue Share by Company (2018-2024)
Table 28. Global Market Anti-Tuberculosis Drug Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Anti-Tuberculosis Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Anti-Tuberculosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Tuberculosis Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into Anti-Tuberculosis Drug Market
Table 33. Key Manufacturers Anti-Tuberculosis Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Anti-Tuberculosis Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Anti-Tuberculosis Drug Sales by Region (2018-2024) & (K Units)
Table 37. Global Anti-Tuberculosis Drug Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Anti-Tuberculosis Drug Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Anti-Tuberculosis Drug Sales Market Share in Value by Region (2018-2024)
Table 40. Global Anti-Tuberculosis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Anti-Tuberculosis Drug Sales by Region (2024-2034) & (K Units)
Table 42. Global Anti-Tuberculosis Drug Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Anti-Tuberculosis Drug Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Anti-Tuberculosis Drug Sales Market Share in Value by Region (2024-2034)
Table 45. Global Anti-Tuberculosis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Anti-Tuberculosis Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Anti-Tuberculosis Drug Sales by Application (2018-2024) & (K Units)
Table 48. Global Anti-Tuberculosis Drug Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Anti-Tuberculosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Anti-Tuberculosis Drug Sales Market Share in Value by Application (2018-2024)
Table 51. Global Anti-Tuberculosis Drug Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Anti-Tuberculosis Drug Sales by Application (2024-2034) & (K Units)
Table 53. Global Anti-Tuberculosis Drug Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Anti-Tuberculosis Drug Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Anti-Tuberculosis Drug Sales Market Share in Value by Application (2024-2034)
Table 56. Global Anti-Tuberculosis Drug Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Anti-Tuberculosis Drug Sales by Application (2018-2024) (K Units)
Table 58. North America Anti-Tuberculosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Anti-Tuberculosis Drug Sales by Application (2018-2024) (K Units)
Table 60. Europe Anti-Tuberculosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Anti-Tuberculosis Drug Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Anti-Tuberculosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Anti-Tuberculosis Drug Sales by Application (2018-2024) (K Units)
Table 64. Latin America Anti-Tuberculosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Anti-Tuberculosis Drug Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Anti-Tuberculosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Anti-Tuberculosis Drug Sales by Country (2018-2024) & (K Units)
Table 68. North America Anti-Tuberculosis Drug Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Anti-Tuberculosis Drug Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Anti-Tuberculosis Drug Sales Market Share in Value by Country (2018-2024)
Table 71. North America Anti-Tuberculosis Drug Sales by Country (2024-2034) & (K Units)
Table 72. North America Anti-Tuberculosis Drug Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Anti-Tuberculosis Drug Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Anti-Tuberculosis Drug Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Anti-Tuberculosis Drug Sales by Country (2018-2024) & (K Units)
Table 76. Europe Anti-Tuberculosis Drug Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Anti-Tuberculosis Drug Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Anti-Tuberculosis Drug Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Anti-Tuberculosis Drug Sales by Country (2024-2034) & (K Units)
Table 80. Europe Anti-Tuberculosis Drug Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Anti-Tuberculosis Drug Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Anti-Tuberculosis Drug Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Anti-Tuberculosis Drug Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Anti-Tuberculosis Drug Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Anti-Tuberculosis Drug Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Anti-Tuberculosis Drug Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Anti-Tuberculosis Drug Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Anti-Tuberculosis Drug Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Anti-Tuberculosis Drug Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Anti-Tuberculosis Drug Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Anti-Tuberculosis Drug Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Anti-Tuberculosis Drug Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Anti-Tuberculosis Drug Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Anti-Tuberculosis Drug Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Anti-Tuberculosis Drug Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Anti-Tuberculosis Drug Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Anti-Tuberculosis Drug Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Anti-Tuberculosis Drug Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Anti-Tuberculosis Drug Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Anti-Tuberculosis Drug Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Anti-Tuberculosis Drug Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Anti-Tuberculosis Drug Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Anti-Tuberculosis Drug Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Anti-Tuberculosis Drug Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Anti-Tuberculosis Drug Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Anti-Tuberculosis Drug Sales Market Share in Value by Country (2024-2034)
Table 107. Lupin Company Information
Table 108. Lupin Introduction and Business Overview
Table 109. Lupin Anti-Tuberculosis Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Lupin Anti-Tuberculosis Drug Product
Table 111. Lupin Recent Development
Table 112. Otsuka Company Information
Table 113. Otsuka Introduction and Business Overview
Table 114. Otsuka Anti-Tuberculosis Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Otsuka Anti-Tuberculosis Drug Product
Table 116. Otsuka Recent Development
Table 117. Sanofi Company Information
Table 118. Sanofi Introduction and Business Overview
Table 119. Sanofi Anti-Tuberculosis Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Sanofi Anti-Tuberculosis Drug Product
Table 121. Sanofi Recent Development
Table 122. Prizer Company Information
Table 123. Prizer Introduction and Business Overview
Table 124. Prizer Anti-Tuberculosis Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Prizer Anti-Tuberculosis Drug Product
Table 126. Prizer Recent Development
Table 127. Abbott Company Information
Table 128. Abbott Introduction and Business Overview
Table 129. Abbott Anti-Tuberculosis Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Abbott Anti-Tuberculosis Drug Product
Table 131. Abbott Recent Development
Table 132. NOVARTIS Company Information
Table 133. NOVARTIS Introduction and Business Overview
Table 134. NOVARTIS Anti-Tuberculosis Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. NOVARTIS Anti-Tuberculosis Drug Product
Table 136. NOVARTIS Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Anti-Tuberculosis Drug Market Trends
Table 140. Anti-Tuberculosis Drug Market Drivers
Table 141. Anti-Tuberculosis Drug Market Challenges
Table 142. Anti-Tuberculosis Drug Market Restraints
Table 143. Anti-Tuberculosis Drug Distributors List
Table 144. Anti-Tuberculosis Drug Downstream Customers
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Tuberculosis Drug Product Picture
Figure 2. Global Anti-Tuberculosis Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anti-Tuberculosis Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Anti-Tuberculosis Drug Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of First-Line Anti-Tuberculosis Drugs
Figure 6. Global First-Line Anti-Tuberculosis Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Second-Line Anti-Tuberculosis Drugs
Figure 8. Global Second-Line Anti-Tuberculosis Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global Anti-Tuberculosis Drug Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Anti-Tuberculosis Drug Sales Market Share by Type in 2022 & 2034
Figure 11. North America Anti-Tuberculosis Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America Anti-Tuberculosis Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe Anti-Tuberculosis Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe Anti-Tuberculosis Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Anti-Tuberculosis Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Anti-Tuberculosis Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America Anti-Tuberculosis Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Anti-Tuberculosis Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Anti-Tuberculosis Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Anti-Tuberculosis Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Tuberculosis Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Tuberculosis Drug Revenue in 2022
Figure 23. Anti-Tuberculosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Global Anti-Tuberculosis Drug Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Anti-Tuberculosis Drug Sales Market Share by Application in 2022 & 2034
Figure 32. North America Anti-Tuberculosis Drug Sales Market Share in Volume by Application in 2022
Figure 33. North America Anti-Tuberculosis Drug Sales Market Share in Value by Application in 2022
Figure 34. Europe Anti-Tuberculosis Drug Sales Market Share in Volume by Application in 2022
Figure 35. Europe Anti-Tuberculosis Drug Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Anti-Tuberculosis Drug Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Anti-Tuberculosis Drug Sales Market Share in Value by Application in 2022
Figure 38. Latin America Anti-Tuberculosis Drug Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Anti-Tuberculosis Drug Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Anti-Tuberculosis Drug Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Anti-Tuberculosis Drug Manufacturing Cost Structure
Figure 43. Anti-Tuberculosis Drug Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries